Cardiac Care and COVID-19: Perspectives in Medical Practice

Myocardial Damage, Myocarditis, and COVID-19

Author(s): Ozgur KARCIOGLU * .

Pp: 19-30 (12)

DOI: 10.2174/9781681088204121010004

* (Excluding Mailing and Handling)


For centuries, complications of cardiovascular disease (CVD) have been documented as the prominent cause of mortality and morbidity worldwide. CVD and pandemic disease precipitate different kinds of damage in the myocardium, which also contribute to the death rates in the vulnerable population.

Almost all viral infections, including COVID-19 and influenza species, have the potential to inflict damage to the myocardial tissue, which also contributes to the severity of the disease itself. For instance, COVID-19 can trigger multiple organ failures with remarkable end results on cardiovascular functions. Its damage to the CVD like myocarditis, myocardial injury, de novo heart failure, acute coronary syndromes including STEMI, and various kinds of fatal and non-fatal dysrhythmias can be mentioned. Although most cases with myocarditis are asymptomatic or exhibit a mild course, it can precipitate acute heart failure and fatal respiratory failure.

Clinicians should be alert in patients with signs and symptoms compatible with myocarditis, pericarditis and/or endocarditis in the pandemic period and routine care because expedient diagnosis and management can prevent adverse outcomes in selected cases.

Keywords: Cardiovascular disease, COVID-19, Diagnosis, Endocarditis, Management, Myocardial damage, Myocarditis, Pericarditis.

Related Journals
Related Books
© 2024 Bentham Science Publishers | Privacy Policy